InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,540.11
(
-0.55%
)
Post# of 13884
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Skier1231

Send PM Follow Ignore
Followers 4
Posts 423
Boards Moderated 0
Alias Born 05/02/2012

Skier1231

Re: None

Thursday, 05/16/2019 11:05:21 AM

Thursday, May 16, 2019 11:05:21 AM

Post# of 13884
The Court issued an order yesterday approving Armory Securities (Extera Partners) as the investment banker for Bertilimumab. They reduced their fees slightly. It was 4%, now its 2.5% on the first 6 million and 4% on anything over 6 million.

Really wondering what happened with the Ceplene sale. It might take a day or two for the Court to issue the Order. Also, the filings seam to appear on line the day after they are issued, so there is a little delay. There might have also been some objections to the sale and the Court is giving some more time for the objections to be filed before making a ruling on the sale?- I guess we'll know soon.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up